Call us 24/7

Continuing Medical Education

CTCA is proud to share the expertise of our physicians through a series of free CME education, both virtual and live. Driven by the goal of improving patient care, our CME program is dedicated to providing a robust, well-rounded portfolio of CME activities that contribute to the greater good of our clinical communities.

Live Event
Dysphagia Palliation in Esophageal Cancer

This educational activity is designed to educate clinicians such as oncologists and gastroenterologists as well as physician-trainees, pharmacists, nurses and allied health professionals involved in the care and management of dysphagia, specifically for patients suffering from esophageal cancer. There are 1700 new cases per year in the U.S. which results in 1600 deaths. Those with esophageal cancer face a high mortality rate and ultimately their major goal is to prolong their life and improve their quality of life. Topics such as screening and diagnosis, managing comorbidities and treatment-related side effects, and palliative care will be covered for oncology specialists to expand their knowledge and transform their practice in cancer care.

Upon completion of this activity, participants will be able to:

  • Discuss the various modalities for management of dysphagia.
  • Select the appropriate modality for management of dysphagia in an esophageal cancer patient.
  • Explain the goals of palliative treatment in esophageal cancer patients.

Faculty:

  • Toufic Kachaamy, MD (Cancer Treatment Centers of America)
  • Madappa Kundranda, MD, PhD (Banner/MD Anderson)

Available Dates:

  • February 21, 2019, Phoenix, AZ

Sign up now

Live Event
CTCA Forum 4.0: Advances in Cancer Management

Advancements in Cancer Management is an educational forum designed to foster dialogue between primary care providers (PCPs) and oncology teams to provide strategies that contribute to integrated cancer care for patients. Panel discussions, case studies and question-and-answer sessions will take place to enhance clinician knowledge and competence. Topics such as: screening high-risk patients, managing cancer pain, treating with immunotherapy and managing adverse events, monitoring for the long-term effects of treatment and/or disease, combining integrative therapies with cancer treatment, and addressing drug-drug interactions will be covered for PCPs to expand their knowledge and transform their practices in cancer care.

Upon completion of this activity, participants will be able to:

  • Explain the use of multimodal analgesia to manage pain and reduce the use of opioids.
  • Describe how integrative therapies and lifestyle change programs are employed as adjunct therapies in the care of cancer patients.
  • Evaluate immuno-oncology approaches in cancer treatment, including patient selection.
  • Describe the appropriate follow-up protocols for identification of pulmonary nodules.
  • Recognize the pathophysiology and clinical presentations of various subtypes of pleural effusions.
  • Describe the various treatment options for each of the various pleural effusions.

Faculty:

  • Kevin Tulipana, DO, FHM (Cancer Treatment Centers of America)
  • Stephen Lynch, MD (Cancer Treatment Centers of America)
  • Vivek Iyer, MD (Cancer Treatment Centers of America)
  • Timothy McCay, DO (Cancer Treatment Centers of America)
  • Larry Ladi, MD, FCCP (Cancer Treatment Centers of America)
  • Ankur Parikh, DO (Cancer Treatment Centers of America)
  • Lorenzo Cohen, PhD (MD Anderson)
  • Larry McKenzie, DO (Cancer Treatment Centers of America)
  • Scott Price, MD (Cancer Treatment Centers of America)

Molecular Tumor Board Series 1

A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic testing, pathology and radiological imaging. Cases discussed include: squamous cell carcinoma of the scalp, papillary serous ovarian cancer, breast carcinoma and lung adenocarcinoma.

Upon completion of this activity, participants will be able to:

  • Utilize skills learned to implement an effective tumor board.
  • Describe genomic testing.
  • Implement genomic profiling into oncology treatment.

Faculty:

  • Pamela Crilley, DO (Cancer Treatment Centers of America)
  • Ricardo H. Alvarez, MD, MSc (Cancer Treatment Centers of America)
  • Shayma Master Kazmi, MD, RPh (Cancer Treatment Centers of America)
  • Arturo Loaiza-Bonilla, MD (Cancer Treatment Centers of America)
  • Maurie Markman, MD (Cancer Treatment Centers of America)
  • Ankur R. Parikh, DO (Cancer Treatment Centers of America)
  • Julian Schink, MD (Cancer Treatment Centers of America)
  • Alan Tan, MD (Cancer Treatment Centers of America)

Available Dates:

  • Ongoing

Sign up now

Molecular Tumor Board Series 2

A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic testing, pathology and radiological imaging. Cases discussed include: breast cancer, large cell neuroendocrine carcinoma of the lung, sino-nasal undifferentiated carcinoma of the head & neck, and adenocarcinoma of the lung.

Upon completion of this activity, participants will be able to:

  • Utilize skills learned to implement an effective tumor board.
  • Describe genomic testing.
  • Implement genomic profiling into oncology treatment.

Faculty:

  • Shayma Maser Kazmi, MD, RPh (Cancer Treatment Centers of America)
  • Arturo Loaiza-Bonilla, MD, MSEd, FACP (Cancer Treatment Centers of America)
  • Bradford Tan, MD (Cancer Treatment Centers of America)
  • Scott Price, MD (Cancer Treatment Centers of America)
  • Pamela Crilley, DO (Cancer Treatment Centers of America)
  • Ankur Parikh, DO (Cancer Treatment Centers of America)
  • David Topolsky, MD (Cancer Treatment Centers of America)
  • Alan Tan, MD (Cancer Treatment Centers of America)
  • Maurie Markman, MD (Cancer Treatment Centers of America)
  • Vicki Doctor, BSN, RN (Cancer Treatment Centers of America)
  • Ricardo Alvarez, MD, MSc (Cancer Treatment Centers of America)
  • Julian Schink, MD (Cancer Treatment Centers of America)

Available Dates:

  • Ongoing

Sign up now